Results 151 to 160 of about 110,519 (362)

Meflin/ISLR is a meningeal cell‐specific marker involved in the development of meninges and meningioma progression

Brain Pathology, EarlyView.
Mesenchymal stromal cell‐and fibroblast‐expressing Linx paralogue (Meflin) is expressed in embryonic meninges and contributes to meningeal homeostasis. In meningiomas, elevated Meflin correlates with higher grade and recurrence. Single‐cell RNA sequencing revealed a Meflin‐high tumor cell subset marked by reduced proliferation, WNT6 expression, and ...
Yukihiro Shiraki, Tomotsugu Kurauchi, Akitoshi Hara, Nobutoshi Esaki, Shinji Mii, Ryota Ando, Akihiro Sakai, Kuniaki Tanahashi, Fumiharu Ohka, Ryuta Saito, Atsushi Natsume, Yuki Hattori, Takaki Miyata, Atsushi Enomoto   +13 more
wiley   +1 more source

Secretory vesicle and cell surface markers for human endocrine pancreatic and pituiary tumors [PDF]

, 1992
Gratzl, Manfred, Gratzl, O., Lahr, G., Langley, K., Vereczkey, C.   +4 more
core   +1 more source

Hereditary Pituitary Tumor Syndromes: Genetic and Clinical Aspects [PDF]

, 2020
Berenice García-Guzmán, Lesly Portocarrero-Ortíz, A. Agustín Dorantes-Argandar, Moisés Mercado   +3 more
openalex   +1 more source

Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors

British Journal of Pharmacology, EarlyView.
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen, Tamás Kovács, Péter Ferdinandy, Zoltán V. Varga   +3 more
wiley   +1 more source

FGFR4 polymorphic alleles modulate mitochondrial respiration: A novel target for somatostatin analog action in pituitary tumors

, 2016
Shereen Ezzat, Ri Wang, Melania Pintilie, L. Sylvia   +3 more
openalex   +2 more sources

The first reported mutations in the pituitary tumor-transforming gene binding factor [PDF]

, 2014
Waraporn Imruetaicharoenchoke, Martin L. Read, Joel Smith, Vicki E. Smith, Bhavika Modasia, Vikki L. Poole, Rachel Watkins, Franklyn Jayne, Kristien Boelaert, Christopher J. McCabe   +9 more
openalex   +1 more source

Novel approaches for drug development against chronic primary pain: A systematic review

British Journal of Pharmacology, EarlyView.
Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus, Éva Borbély, Andreas Goebel, Ralf Baron, Zsófia Hajna, Zsuzsanna Helyes   +5 more
wiley   +1 more source

Transcriptional targets for pituitary tumor-transforming gene-1 [PDF]

, 2009
Yunguang Tong, Tamar Eigler
openalex   +1 more source

Acromegaly in a Young Women With Pituitary Hyperplasia Secondary to a Neuroendocrine Tumor [PDF]

, 2021
Gul Bano
openalex   +1 more source

Editorial: pituitary tumors [PDF]

Journal of Neuro-Oncology, 2014
Marvin, Bergsneider, Anthony P, Heaney, John Y K, Lee   +2 more
openaire   +2 more sources